                         SEQUENCE LISTING

<110>  ANTAROS MEDICAL AB
 
<120>  Selective GIP receptor agonists comprising a chelating 
       moiety for imaging and therapy purposes

<130>  21124860

<150>  EP20315081.8
<151>  2020-03-31

<160>  6    

<170>  PatentIn version 3.5

<210>  1
<211>  42
<212>  PRT
<213>  Homo sapiens

<220>
<221>  MOD_RES
<222>  (42)..(42)

<400>  1

Tyr Ala Glu Gly Thr Phe Ile Ser Asp Tyr Ser Ile Ala Met Asp Lys 
1               5                   10                  15      


Ile His Gln Gln Asp Phe Val Asn Trp Leu Leu Ala Gln Lys Gly Lys 
            20                  25                  30          


Lys Asn Asp Trp Lys His Asn Ile Thr Gln 
        35                  40          
              

<210>  2
<211>  30
<212>  PRT
<213>  Homo sapiens

<220>
<221>  MOD_RES
<222>  (30)..(30)
<223>  Lys is modified with an NH2 group

<400>  2

Tyr Ala Glu Gly Thr Phe Ile Ser Asp Tyr Ser Ile Ala Met Asp Lys 
1               5                   10                  15      


Ile His Gln Gln Asp Phe Val Asn Trp Leu Leu Ala Gln Lys 
            20                  25                  30          


     
<210>  3
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  artificial polypeptide

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is is Aminoisobutyric acid (Aib)

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  Xaa is Lys derivatized with 
       (4,7,10-Tris-carboxymethyl-1,4,7,10-tetraaza-cyclododec-1-yl)-acetyl

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  Amidated C-terminus

<400>  3

Tyr Xaa Glu Gly Thr Phe Ile Ser Asp Leu Ser Ile Ala Leu Asp Arg 
1               5                   10                  15      


Ile His Gln Glu Glu Phe Ile Glu Trp Leu Leu Ala Gly Gly Xaa
            20                  25                  30          
              

<210>  4
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  artificial polypeptide

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is is Aminoisobutyric acid (Aib)

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  Xaa is Lys derivatized with 
       (4,7,10-Tris-carboxymethyl-1,4,7,10-tetraaza-cyclododec-1-yl)-acetyl 
	with complexed Gallium

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  Amidated C-terminus

<400>  4

Tyr Xaa Glu Gly Thr Phe Ile Ser Asp Leu Ser Ile Ala Leu Asp Arg 
1               5                   10                  15      


Ile His Gln Glu Glu Phe Ile Glu Trp Leu Leu Ala Gly Gly Xaa
            20                  25                  30    


<210>  5
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  artificial polypeptide

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is is Aminoisobutyric acid (Aib)

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  Xaa is Cys derivatized with 
       2-[2-(4,7,10-Tris-carboxymethyl-1,4,7,10-tetraaza-cyclododec-1-yl
       )-ethanesulfonyl]-ethyl

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  Amidated C-terminus

<400>  5

Tyr Xaa Glu Gly Thr Phe Ile Ser Asp Leu Ser Ile Ala Leu Asp Arg 
1               5                   10                  15      


Ile His Gln Glu Glu Phe Ile Gln Trp Leu Leu Ala Gly Gly Xaa
            20                  25                  30       



<210>  6
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  artificial polypeptide

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Xaa is is Aminoisobutyric acid (Aib)

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  Xaa is Cys derivatized with 
       2-[2-(4,7,10-Tris-carboxymethyl-1,4,7,10-tetraaza-cyclododec-1-yl
       )-ethanesulfonyl]-ethyl with complexed Gallium

<220>
<221>  MOD_RES
<222>  (31)..(31)
<223>  Amidated C-terminus

<400>  6

Tyr Xaa Glu Gly Thr Phe Ile Ser Asp Leu Ser Ile Ala Leu Asp Arg 
1               5                   10                  15      


Ile His Gln Glu Glu Phe Ile Gln Trp Leu Leu Ala Gly Gly Xaa
            20                  25                  30    



   




